Baxter is an Ilinois-based healthcare company that designs and distributes nutritional, renal and surgical care products for medical centers.
Business Model:
Revenue: $13.5B
Employees: 10,001-999,999
Address: 1 Baxter Parkway
City: Deerfield
State: IL
Zip: 60015
Country: US
Baxter is an Ilinois-based healthcare company that designs and distributes nutritional, renal and surgical care products for medical centers.
Contact Phone:
+18442945418
Contact Email:
Listed Exchange:
NYSE
IPO Date:
1/13/1978
Ticker Symbol:
BAX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2014 | Naurex | Series C | 0 |
10/2013 | Opsona | Series C | 0 |
4/2013 | Opsona | Series C | 0 |
5/2020 | Ayogo Health | Series B | 0 |
6/2013 | Ocular Therapeutix | Series D | 23.8M |
1/2013 | Zytoprotec | Series A | 2.7M |
10/2012 | Gliknik | Series B | 9.9M |
1/2022 | Medically Home | Venture Round | 0 |
12/2012 | Naurex | Series B | 0 |
3/2022 | NovaXS Biotech | Seed Round | 0 |
11/2021 | Walela | Seed Round | 0 |
1/2014 | Xenetic Biosciences | Post-IPO Equity | 10M |
3/2022 | NovaXS Biotech | Seed Round | 0 |
1/2022 | Medically Home | Venture Round | 0 |
11/2021 | Walela | Seed Round | 0 |
5/2020 | Ayogo Health | Series B | 0 |
5/2014 | Naurex | Series C | 0 |
1/2014 | Xenetic Biosciences | Post-IPO Equity | 0 |
10/2013 | Opsona | Series C | 0 |
6/2013 | Ocular Therapeutix | Series D | 0 |
4/2013 | Opsona | Series C | 0 |
1/2013 | Zytoprotec | Series A | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2021 | Grant | 1 | $1.8M |
German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) |
4/2021 | Grant | $1.8M |
German Federal Ministry of Education and Research |
1/1978 | IPO | - | 5/2019 | Post-IPO Debt | $1.7B | 9/2021 | Post-IPO Debt | $2.5B |
JPMorgan Chase Bank |
1/1978 | IPO | - |
---|
Announced Date | Name | Price |
---|---|---|
9/2021 | Hill-Rom | |
12/2019 | Seprafilm | |
9/2019 | Cheetah Medical | |
12/2016 | Claris Injectables | |
3/2015 | SuppreMol | |
7/2014 | AesRx | |
4/2014 | Chatham Therapeutics | |
9/2013 | FLOWSENSE | |
9/2013 | Gambro | |
2/2012 | Synovis Life Technologies |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|